Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SLx-4090 with Metformin in Type 2 Diabetes
NCT00871936Phase 2Completed
- Sponsor
- Response Pharmaceuticals
- Start
- Apr 2009
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of KD026 in type 2 diabetes mellitus (T2DM), sponsored by Response Pharmaceuticals. Started Apr 2009; status: completed.
02
Drugs
KD026
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00871936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00871936.